Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Solasta Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Solasta Ventures

Solasta Ventures

Operating

Solasta Ventures: A leading healthcare investment firm innovating care for unmet medical needs.

Location
Boston, MA, US
Founded
2020
Firm
Compare
Portfolio
Employees
Website

Solasta Ventures is a healthcare and life sciences investment firm focused on advancing the standard of care for diseases with unmet medical needs. As a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm, Solasta Ventures targets innovative therapeutics and discovery platforms. The firm typically invests in Series A through Series D rounds, with significant involvement in Series B and C stages.

Notable portfolio companies include Atea Pharmaceuticals, Kymera Therapeutics, and Carisma Therapeutics. The firm is led by key decision-makers with deep scientific expertise and extensive networks. Solasta Ventures offers unique value-add services such as leveraging scientific knowledge and strategic partnerships to support the growth and success of their portfolio companies.

Solasta Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments25
Current Portfolio Count22
Total Portfolio Exits0

Top Investment Stages

Series B9 (39.1%)
Series C5 (21.7%)
Post Ipo Equity3 (13.0%)
Series A3 (13.0%)
Series Unknown3 (13.0%)

Stage Mix

Series B 39%Series C 22%Post Ipo Equity 13%Series A 13%Series Unknown 13%

Concentration shown as share of disclosed investments by stage.

Recent Investments

EvolveImmune Therapeutics logo

EvolveImmune Therapeutics

ReCode Therapeutics logo

ReCode Therapeutics

Boxhub logo

Boxhub

Prime Roots logo

Prime Roots

Ensoma logo

Ensoma

Carisma Therapeutics logo

Carisma Therapeutics

Carbon Biosciences logo

Carbon Biosciences

Rescale logo

Rescale

Immunitas Therapeutics logo

Immunitas Therapeutics

Ridecell logo

Ridecell

Exo logo

Exo

Seer logo

Seer

HotSpot Therapeutics logo

HotSpot Therapeutics

Atea Pharmaceuticals logo

Atea Pharmaceuticals

Kymera Therapeutics logo

Kymera Therapeutics

Orionis Biosciences logo

Orionis Biosciences

Kezar Life Sciences logo

Kezar Life Sciences

Trefoil Therapeutics logo

Trefoil Therapeutics

Apellis Pharmaceuticals logo

Apellis Pharmaceuticals

Chameleon Biosciences logo

Chameleon Biosciences

Rapt Therapeutics logo

Rapt Therapeutics

Amphivena Therapeutics logo

Amphivena Therapeutics

Solasta Ventures - Similar Investment Firms

Solas BioVentures logo

Solas BioVentures

solasbio.com

Seae Ventures logo

Seae Ventures

Optum Ventures logo

Optum Ventures

optumventures.com

Versant Ventures logo

Versant Ventures

Avestria logo

Avestria

avestria.vc

DaVita Venture Group logo

DaVita Venture Group

Arkitekt Ventures logo

Arkitekt Ventures

UnityPoint Health Ventures logo

UnityPoint Health Ventures

unitypoint.org

Quark Venture logo

Quark Venture

quarkventure.com

Bioventures Investors logo

Bioventures Investors

Sky Ventures Group logo

Sky Ventures Group

sky-ventures.com

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Salkantay Ventures logo

Salkantay Ventures

Solon Ventures logo

Solon Ventures

Venture Investors logo

Venture Investors

Solasta Ventures - Classification

Also Known As
  • Solasta Ventures, Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end